Daxor ROE 2010-2011 | DXR

Current and historical return on equity (ROE) values for Daxor (DXR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Daxor ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2011-12-31 $-0.01B $0.04B -14.46%
2011-09-30 $0.00B $0.04B -6.78%
2011-06-30 $0.00B $0.05B 8.56%
2011-03-31 $0.00B $0.05B 8.70%
2010-12-31 $0.01B $0.05B 10.81%
2010-09-30 $0.00B $0.05B 4.30%
2010-06-30 $0.00B $0.04B 4.26%
2010-03-31 $0.01B $0.05B 16.84%
2009-12-31 $0.01B $0.05B 13.71%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.052B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.978B 19.09
Encompass Health (EHC) United States $12.307B 24.59
DaVita (DVA) United States $9.819B 14.04
Elanco Animal Health (ELAN) United States $8.838B 19.77
Chemed (CHE) United States $6.645B 22.25
RadNet (RDNT) United States $5.353B 193.31
Option Care Health (OPCH) United States $4.554B 19.49
Addus HomeCare (ADUS) United States $2.147B 23.15
LifeStance Health (LFST) United States $2.096B 0.00
Astrana Health (ASTH) United States $1.678B 58.69
Aveanna Healthcare Holdings (AVAH) United States $1.552B 28.58
U.S Physical Therapy (USPH) United States $1.300B 32.50
Atai Life Sciences (ATAI) Germany $1.016B 0.00
Pennant (PNTG) United States $0.852B 30.05
MEDIROM Healthcare Technologies (MRM) Japan $0.056B 0.00
Psychemedics (PMD) United States $0.000B 0.00